tiprankstipranks
Trending News
More News >
Gilead Sciences (GILD)
NASDAQ:GILD
US Market

Gilead Sciences (GILD) Stock Forecast & Price Target

Compare
13,237 Followers
See the Price Targets and Ratings of:

GILD Analyst Ratings

Moderate Buy
19Ratings
14 Buy
5 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Gilead
Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GILD Stock 12 Month Forecast

Average Price Target

$120.53
▲(17.59% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $120.53 with a high forecast of $140.00 and a low forecast of $92.00. The average price target represents a 17.59% change from the last price of $102.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"60":"$60","141":"$141","80.25":"$80.3","100.5":"$100.5","120.75":"$120.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$140.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":120.53,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$120.53</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$92.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[60,80.25,100.5,120.75,141],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,103.25,106.07692307692308,108.90384615384616,111.73076923076923,114.5576923076923,117.38461538461539,120.21153846153847,123.03846153846155,125.86538461538461,128.69230769230768,131.51923076923077,134.34615384615384,137.17307692307693,{"y":140,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,103.25,104.57923076923078,105.90846153846154,107.23769230769231,108.56692307692308,109.89615384615385,111.22538461538461,112.55461538461539,113.88384615384615,115.21307692307693,116.54230769230769,117.87153846153846,119.20076923076923,{"y":120.53,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,103.25,102.38461538461539,101.51923076923077,100.65384615384616,99.78846153846153,98.92307692307692,98.0576923076923,97.1923076923077,96.32692307692308,95.46153846153847,94.59615384615384,93.73076923076923,92.86538461538461,{"y":92,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":63.14,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.94,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.97,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.63,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.08,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.66,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.14,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.59,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.73,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.51,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.28,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$140.00Average Price Target$120.53Lowest Price Target$92.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on GILD
Tim AndersonBank of America Securities
Bank of America Securities
$126
Buy
22.93%
Upside
Reiterated
05/14/25
TD Cowen
$110
Buy
7.32%
Upside
Reiterated
05/06/25
Argus Research Analyst forecast on GILD
Jasper HellwegArgus Research
Argus Research
$120
Buy
17.07%
Upside
Reiterated
05/05/25
Mizuho Securities Analyst forecast on GILD
Salim SyedMizuho Securities
Mizuho Securities
$100$117
Buy
14.15%
Upside
Reiterated
05/02/25
Maxim Group
Hold
Reiterated
04/30/25
HSBC
$82$93
Hold
-9.27%
Downside
Reiterated
04/28/25
Truist Financial Analyst forecast on GILD
Asthika GoonewardeneTruist Financial
Truist Financial
Hold
Reiterated
04/28/25
Jefferies Analyst forecast on GILD
Michael YeeJefferies
Jefferies
$130
Buy
26.83%
Upside
Reiterated
04/27/25
Morgan Stanley Analyst forecast on GILD
Terence FlynnMorgan Stanley
Morgan Stanley
$130$135
Buy
31.71%
Upside
Reiterated
04/25/25
Citi
$125
Buy
21.95%
Upside
Reiterated
04/25/25
Needham
Hold
Reiterated
04/25/25
Oppenheimer Analyst forecast on GILD
Matthew BieglerOppenheimer
Oppenheimer
$132$125
Buy
21.95%
Upside
Reiterated
04/25/25
Leerink Partners Analyst forecast on GILD
Daina GrayboschLeerink Partners
Leerink Partners
Buy
Reiterated
04/25/25
Wells Fargo Analyst forecast on GILD
Mohit BansalWells Fargo
Wells Fargo
$140
Buy
36.59%
Upside
Reiterated
04/24/25
BMO Capital Analyst forecast on GILD
Evan SeigermanBMO Capital
BMO Capital
$120
Buy
17.07%
Upside
Reiterated
04/24/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on GILD
Tim AndersonBank of America Securities
Bank of America Securities
$126
Buy
22.93%
Upside
Reiterated
05/14/25
TD Cowen
$110
Buy
7.32%
Upside
Reiterated
05/06/25
Argus Research Analyst forecast on GILD
Jasper HellwegArgus Research
Argus Research
$120
Buy
17.07%
Upside
Reiterated
05/05/25
Mizuho Securities Analyst forecast on GILD
Salim SyedMizuho Securities
Mizuho Securities
$100$117
Buy
14.15%
Upside
Reiterated
05/02/25
Maxim Group
Hold
Reiterated
04/30/25
HSBC
$82$93
Hold
-9.27%
Downside
Reiterated
04/28/25
Truist Financial Analyst forecast on GILD
Asthika GoonewardeneTruist Financial
Truist Financial
Hold
Reiterated
04/28/25
Jefferies Analyst forecast on GILD
Michael YeeJefferies
Jefferies
$130
Buy
26.83%
Upside
Reiterated
04/27/25
Morgan Stanley Analyst forecast on GILD
Terence FlynnMorgan Stanley
Morgan Stanley
$130$135
Buy
31.71%
Upside
Reiterated
04/25/25
Citi
$125
Buy
21.95%
Upside
Reiterated
04/25/25
Needham
Hold
Reiterated
04/25/25
Oppenheimer Analyst forecast on GILD
Matthew BieglerOppenheimer
Oppenheimer
$132$125
Buy
21.95%
Upside
Reiterated
04/25/25
Leerink Partners Analyst forecast on GILD
Daina GrayboschLeerink Partners
Leerink Partners
Buy
Reiterated
04/25/25
Wells Fargo Analyst forecast on GILD
Mohit BansalWells Fargo
Wells Fargo
$140
Buy
36.59%
Upside
Reiterated
04/24/25
BMO Capital Analyst forecast on GILD
Evan SeigermanBMO Capital
BMO Capital
$120
Buy
17.07%
Upside
Reiterated
04/24/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Gilead Sciences

Which Analyst Should I Follow If I Want to Buy GILD and Sell After:
1 Month
xxx
Success Rate
18/29 ratings generated profit
62%
Average Return
+2.41%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.07% of your transactions generating a profit, with an average return of +2.41% per trade.
3 Months
xxx
Success Rate
19/29 ratings generated profit
66%
Average Return
+3.01%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.52% of your transactions generating a profit, with an average return of +3.01% per trade.
1 Year
Success Rate
21/29 ratings generated profit
72%
Average Return
+16.72%
reiterated a buy rating 13 days ago
Copying Tyler Van Buren's trades and holding each position for 1 Year would result in 72.41% of your transactions generating a profit, with an average return of +16.72% per trade.
2 Years
xxx
Success Rate
48/59 ratings generated profit
81%
Average Return
+20.36%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.36% of your transactions generating a profit, with an average return of +20.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GILD Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
40
42
43
56
43
Hold
20
13
10
15
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
60
55
53
71
52
In the current month, GILD has received 43 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. GILD average Analyst price target in the past 3 months is 120.53.
Each month's total comprises the sum of three months' worth of ratings.

GILD Financial Forecast

GILD Earnings Forecast

Next quarter’s earnings estimate for GILD is $1.96 with a range of $1.86 to $2.25. The previous quarter’s EPS was $1.81. GILD beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
Next quarter’s earnings estimate for GILD is $1.96 with a range of $1.86 to $2.25. The previous quarter’s EPS was $1.81. GILD beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.

GILD Sales Forecast

Next quarter’s sales forecast for GILD is $6.96B with a range of $6.74B to $7.27B. The previous quarter’s sales results were $6.65B. GILD beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.50% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
Next quarter’s sales forecast for GILD is $6.96B with a range of $6.74B to $7.27B. The previous quarter’s sales results were $6.65B. GILD beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.50% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.

GILD Stock Forecast FAQ

What is GILD’s average 12-month price target, according to analysts?
Based on analyst ratings, Gilead Sciences’s 12-month average price target is 120.53.
    What is GILD’s upside potential, based on the analysts’ average price target?
    Gilead Sciences has 17.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GILD a Buy, Sell or Hold?
          Gilead Sciences has a consensus rating of Moderate Buy which is based on 14 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Gilead Sciences’s price target?
            The average price target for Gilead Sciences is 120.53. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $140.00 ,the lowest forecast is $92.00. The average price target represents 17.59% Increase from the current price of $102.5.
              What do analysts say about Gilead Sciences?
              Gilead Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of GILD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis